Dachaigh › Ailse Endometrial › Oklahoma
Sgrùdaidhean clionaigeach Ailse Endometrial ann an Oklahoma
Tha 28 sgrùdaidhean airson Ailse Endometrial a’ lorg phàirtichean aig làraichean ann an Oklahoma.
Bailtean ann an Oklahoma
Teacsa sgrùdaidh oifigeil (Beurla)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- University of Oklahoma Health Sciences Center, Oklahoma City
A’ fastadhÌre 2
Gach aois · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05564377Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Dàmh 2026 · NCT05950464The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Oklahoma, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Dàmh 2026 · NCT07198074Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- University of Oklahoma Health Sciences Center, Oklahoma City
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 28 Sult 2026 · NCT05112601Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05867251Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Stephenson Cancer Center, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 25 Sult 2026 · NCT03564340Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- University of Oklahoma Health Sciences Center, Oklahoma City
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 24 Sult 2026 · NCT05640999Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Oklahoma, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06128551A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6047), Tulsa
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 17 Sult 2026 · NCT06952504A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- Peggy & Charles Stephenson Oklahoma Cancer Center, Oklahoma City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 17 Sult 2026 · NCT06340568DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Oklahoma City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 3 Sult 2026 · NCT06989112Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- OU Health Stephenson Cancer Center, Oklahoma City
A’ fastadhÌre 1
Aoisean 15 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT06276491A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- Stephenson Cancer Center at OU Health, Oklahoma City
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 21 Lùna 2026 · NCT05548296A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Oklahoma City
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07182149A Study of DM002 in Patients With Advanced Solid Tumors
- University of Oklahoma Health Sciences Center, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT06751329Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of Oklahoma - Health Sciences Center, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT05579366A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Stephenson Cancer Center, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT04657068Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - OKC, Oklahoma City
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT07327489A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Stephenson Cancer Center Oklahoma University Health, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT05377996A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
- University of Oklahoma Health Stephenson Cancer Center, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 1 Gibl 2026 · NCT04486352Uterine Preservation Via Lifestyle Transformation
- University of Oklahoma, Oklahoma City
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 20 Faoi 2026 · NCT05903131A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Oklahoma City
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Faoi 2026 · NCT06999187Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
- University of Oklahoma, Oklahoma City
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 11 Dùbh 2025 · NCT06795009Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
- Oklahoma University Stephenson Cancer Center, Oklahoma City
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Samh 2025 · NCT05997017A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
- University of Oklahoma, Oklahoma City
A’ fastadhÌre 2
Aoisean 18 gu 70 · Banairean · Air ùrachadh 30 Dàmh 2025 · NCT06481592SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Oklahoma Cancer Specialists and Research Institute, Tulsa
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Cèit 2024 · NCT05797831Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.